Nathan Jenkins

Nathan Jenkins


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2015 in Experimental Physiology
Verified
Journal Article
Closed access
PDF file
KLKasey A. Lansford
Kasey A. Lansford
DSDaniel D. Shill
Daniel D. Shill
ADAndrew B. Dicks
Andrew B. Dicks
MMMeagan P. Marshburn
Meagan P. Marshburn
WSW. Michael Southern
W. Michael Southern
NJNathan Jenkins
Nathan Jenkins

18 September 2016 in The Journal of Physiology
Verified
Journal Article
Closed access
PDF file
DSDaniel D. Shill
Daniel D. Shill
WSW. Michael Southern
W. Michael Southern
TWT. Bradley Willingham
T. Bradley Willingham
KLKasey A. Lansford
Kasey A. Lansford
KMKevin K. McCully
Kevin K. McCully
NJNathan Jenkins
Nathan Jenkins

26 March 2018 in Experimental Physiology
Verified
Journal Article
Closed access
PDF file
DSDaniel D. Shill
Daniel D. Shill
KLKasey A. Lansford
Kasey A. Lansford
HHHannah K. Hempel
Hannah K. Hempel
JCJarrod A. Call
Jarrod A. Call
JMJonathan R. Murrow
Jonathan R. Murrow
NJNathan Jenkins
Nathan Jenkins

24 June 2014 in Physiological Reports
Verified
Journal Article
Open access
PDF file
JHJessica A. Hiemstra
Jessica A. Hiemstra
MGManuel Gutierrez-Aguilar
Manuel Gutierrez-Aguilar
KMKurt D. Marshall
Kurt D. Marshall
Kyle S McCommisKyle S McCommis
Kyle S McCommis
PZPamela J. Zgoda
Pamela J. Zgoda
CECraig A. Emter
Craig A. Emter
We recently developed a clinically relevant mini‐swine model of heart failure with preserved ejection fraction (HFpEF), in which diastolic dysfunction was associated with increased mitochondrial permeability transition (MPT). Early diastolic function is ATP and Ca2+‐dependent, thus, we hypothesized chronic low doses of cyclosporine (CsA) would preserve mitochondrial function via inhibition of MPT and subsequently maintain normal cardiomyocyte Ca2+ handling and contractile characteristics. Left ventricular cardiomyocytes were isolated from aortic‐banded Yucatan mini‐swine divided into three groups; control nonbanded (CON), HFpEF nontreated (HF), and HFpEF treated with CsA (HF‐CsA). CsA mitigated the deterioration of mitochondrial function observed in HF animals, including functional uncoupling of Complex I‐dependent mitochondrial respiration and increased susceptibility to MPT. Attenuation of mitochondrial dysfunction in the HF‐CsA group was not associated with commensurate improvement in cardiomyocyte Ca2+ handling or contractility. Ca2+ transient amplitude was reduced and transient time to peak and recovery (tau) prolonged in HF and HF‐CsA groups compared to CON. Alterations in Ca2+ transient parameters observed in the HF and HF‐CsA groups were associated with decreased cardiomyocyte shortening and shortening rate. Cellular function was consistent with impaired in vivo systolic and diastolic whole heart function. A significant systemic hypertensive response to CsA was observed in HF‐CsA animals, and may have played a role in the accelerated the development of heart failure at both the whole heart and cellular levels. Given the significant detriment to cardiac function observed in response to CsA, our findings suggest chronic CsA treatment is not a viable therapeutic option for HFpEF.

15 April 2014 in Journal of Applied Physiology
Verified
Journal Article
Closed access
PDF file
NJNathan Jenkins
Nathan Jenkins
JPJaume Padilla
Jaume Padilla
PTPamela K. Thorne
Pamela K. Thorne
Jeffrey MartinJeffrey Martin
Jeffrey Martin
RRR. Scott Rector
R. Scott Rector
MLM. Harold Laughlin
M. Harold Laughlin
We employed next-generation RNA sequencing (RNA-Seq) technology to determine the influence of obesity on global gene expression in skeletal muscle feed arteries. Transcriptional profiles of the gastrocnemius and soleus muscle feed arteries (GFA and SFA, respectively) and aortic endothelial cell-enriched samples from obese Otsuka Long-Evans Tokushima Fatty (OLETF) and lean Long-Evans Tokushima Otsuka (LETO) rats were examined. Obesity produced 282 upregulated and 133 downregulated genes in SFA and 163 upregulated and 77 downregulated genes in GFA [false discovery rate (FDR) < 10%] with an overlap of 93 genes between the arteries. In LETO rats, there were 89 upregulated and 114 downregulated genes in the GFA compared with the SFA. There were 244 upregulated and 275 downregulated genes in OLETF rats (FDR < 10%) in the GFA compared with the SFA, with an overlap of 76 differentially expressed genes common to both LETO and OLETF rats in both the GFA and SFA. A total of 396 transcripts were found to be differentially expressed between LETO and OLETF in aortic endothelial cell-enriched samples. Overall, we found 1) the existence of heterogeneity in the transcriptional profile of the SFA and GFA within healthy LETO rats, 2) that this between-vessel heterogeneity was markedly exacerbated in the hyperphagic, obese OLETF rat, and 3) a greater number of genes whose expression was altered by obesity in the SFA compared with the GFA. Also, results indicate that in OLETF rats the GFA takes on a relatively more proatherogenic phenotype compared with the SFA.

25 October 2013 in Experimental Physiology
Verified
Journal Article
Open access
PDF file
NJNathan Jenkins
Nathan Jenkins
JPJaume Padilla
Jaume Padilla
Jeffrey MartinJeffrey Martin
Jeffrey Martin
JCJacqueline M. Crissey
Jacqueline M. Crissey
JTJohn P. Thyfault
John P. Thyfault
MLM. Harold Laughlin
M. Harold Laughlin
• What is the central question of this study? This study investigated the influence of obesity on insulin‐induced vasomotor reactivity in rat skeletal muscle feed arteries. • What is the main finding and its importance? Irrespective of obesity, the gastrocnemius feed artery displayed diminished insulin‐induced vasodilatory response compared to the soleus feed artery. This difference between the arteries was abolished in the presence of an endothelin‐1 receptor antagonist. Therefore, our findings demonstrate that insulin‐induced endothelin‐1 production is not uniform among all skeletal muscle resistance vessels. The vascular actions of insulin are complex, because it can stimulate both nitric oxide‐mediated dilatation and endothelin (ET)‐1‐mediated constriction. We examined vasoreactivity to insulin in isolated feed arteries of the gastrocnemius (GFA) and soleus muscles (SFA) of 32‐week‐old Long–Evans Tokushima Otsuka (LETO) and Otsuka Long–Evans Tokushima fatty (OLETF) rats, a hyperphagic rodent model of obesity and insulin resistance. The insulin‐induced vasoreactivity of SFA and GFA was similar in LETO (healthy) and OLETF (obese/insulin‐resistant) rats. However, examination of between‐vessel effects revealed a number of novel insights into the heterogeneous vascular effects of insulin. Soleus feed arteries dilated more than GFA in LETO at 100 and 1000 μIU ml−1 insulin (23 versus 6 and 28 versus 0%, respectively; P < 0.05 for between‐vessel differences). Likewise, in OLETF rats there was significantly greater dilatation in SFA than GFA at 10, 100 and 1000 μIU ml−1 insulin (28 versus 3, 30 versus 0 and 34 versus 0%, respectively; all P < 0.05). In the presence of 3 μm tezosentan, a non‐specific endothelin‐1 receptor blocker, insulin‐induced dilatation of the GFA was enhanced such that differences between vessels were largely abolished in both groups. Furthermore, acetylecholine‐induced dilatation was significantly greater in SFA than GFA within each group, whereas sodium nitroprusside‐induced dilatory responses were greater in the GFA compared with the SFA. Overall, our findings indicate that the insulin/endothelin‐1 vasoconstrictor pathway is more active in GFA than in SFA, independent of obesity in the OLETF rat model.